DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer.

Authors Zou Q, Wang X, Ren D. et al
Citation J Immunother Cancer. 2021 Sep;9(9):e002671.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/34548385/
PMCID PMC8458312

Read this next

DNA Methylation Signatures and the Contribution of Age-Associated Methylomic Drift to Carcinogenesis in Early-Onset Colorectal Cancer.